e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Are needles enough: the value of different approaches
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of the integrated PET/CT and the EBUS-TBNA of lymph nodes in patients with suspected cancer
H. Hermosa, F. Andreo, E. Cases, J. Sanz, F. Caro, J. Abad, J. Bechini, E. Castellà, E. Monsó (Badalona, Valencia, Spain)
Source:
Annual Congress 2010 - Are needles enough: the value of different approaches
Session:
Are needles enough: the value of different approaches
Session type:
Thematic Poster Session
Number:
726
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Hermosa, F. Andreo, E. Cases, J. Sanz, F. Caro, J. Abad, J. Bechini, E. Castellà, E. Monsó (Badalona, Valencia, Spain). Evaluation of the integrated PET/CT and the EBUS-TBNA of lymph nodes in patients with suspected cancer. Eur Respir J 2010; 36: Suppl. 54, 726
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Probability model for malignancy in hilar and mediastinal lymph nodes in lung cancer based on PET-CT and EBUS
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019
EBUS-TBNA of lymph nodes in the radiologically and PET normal mediastinum in patients with lung cancer
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008
The role of PET-CT in mediastinal lymph node staging in NSCLC
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Sampling of ipsilateral mediastinal nodes by EBUS-TBNA in lung cancer staging
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012
Is there any added value of EBUS-TBNA to the identification of non-avid PET-CT lymph nodes?
Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules
Year: 2018
Usefulness of F-18 FDG PET/CT to identify metastatic mediastinal lymph node in NSCLC patients with bilateral benign mediastinal lymph node hyperplasia
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Microbiological study of mediastinal lymph node biopsy from patients with sarcoidosis and lung cancer
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Role of molecular and cellular techniques applied to EBUS-TBNA of mediastinal lymph nodes for lung cancer staging
Source: Annual Congress 2012 - EBUS-TBNA: a never ending story
Year: 2012
Endobronchial and endoscopic ultrasound for assessment of PET positive mediastinal lymph nodes
Source: Eur Respir J 2007; 30: Suppl. 51, 665s
Year: 2007
Primary nodal anthracosis identified by EBUS-TBNA as a cause of high PET-CT FDG uptake in mediastinal lymph nodes: case series
Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Year: 2018
EBUS-TBNA for the clarification of PET positive intrathoracic lymph nodes: a multi-centre experience
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008
Etiology of mediastinal lymph node enlargement in patients who underwent EBUS-TBNA.
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
EBUS-TBNA in the diagnose of intrathoracic lymph nodes of patients with extratoracic malignancy
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
EUS-FNA and EBUS: the role of ultrasound in endoscopic diagnosis of mediastinal lymph nodes
Source: Annual Congress 2007 - EUS-FNA and EBUS: the role of ultrasound in endoscopic diagnosis of mediastinal lymph nodes
Year: 2007
EBUS-TBNA for mediastinal restaging
Source: Annual Congress 2006 - Lung cancer staging and miscellaneous
Year: 2006
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007
PET and endobronchial ultrasound. SUV value of mediastinal lymph nodes suspicious for malignancy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
EBUS-TBNA in PET-positive lymphadenopathies in treated cancer patients
Source: ERJ Open Res, 3 (4) 00009-2017; 10.1183/23120541.00009-2017
Year: 2017
Diagnostic utility of EBUS-TBNA according to lymph node stations in sarcoidosis
Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound
Year: 2020
The diagnostic value of EBUS-TBNA for small mediastinal and hilar lymph nodes.
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept